Latest News about Briefs
Recent news which mentions Briefs
Chemours Q4 Earnings: Mixed Results, Moderate Outlook, 'Pathway To Thrive' In Action & More
February 18, 2025
From Benzinga
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
February 18, 2025
From Benzinga
Tesla Files Fresh Lawsuit Against Matthews After Court Defeat
February 18, 2025
From Benzinga
Baidu Q4 Earnings: AI Cloud Grows, Margin Slides, Expects AI Investments To Bear Fruit In 2025
February 18, 2025
From Benzinga
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
February 18, 2025
From Benzinga
TotalEnergies Powers Up With Air Liquide For Hydrogen Breakthrough
February 18, 2025
From Benzinga
From Benzinga
Asia And Europe Markets Mixed, Oil Edges Higher After Pipeline Attack - Global Markets Today While US Slept
February 18, 2025
From Benzinga
Consumer Tech News (Feb 10-Feb 14): US & UK Denied Signing Global AI Safety Declaration, Musk To Settle $10 Million Trump Lawsuit & More
February 16, 2025
From Benzinga
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
February 16, 2025
From Benzinga
Reddit, GoDaddy & Trade Desk Are Among Top 11 Large-Cap Losers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
February 16, 2025
From Benzinga
Super Micro Computer, Intel, Alibaba And CVS Are Among Top 13 Large-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
February 16, 2025
From Benzinga
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
February 14, 2025
From Benzinga
From Benzinga
Twilio's Q4 Delivers On Expectations, But Guidance And AI Strategy Divide Analysts
February 14, 2025
From Benzinga
AstraZeneca's Imfinzi Perioperative Regimen Shows Improved Survival Outcomes In Bladder Cancer Patients
February 14, 2025
From Benzinga
Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancer
February 14, 2025
From Benzinga
Applied Materials Navigates China Slowdown, Analysts See Early Recovery Despite Soft Guidance
February 14, 2025
From Benzinga
Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate
February 14, 2025
From Benzinga
What's Going On With Lucid Stock Today?
February 14, 2025
From Benzinga
Nvidia Shifts Strategy, Boosts WeRide Investment, Trims Arm Stake
February 14, 2025
From Benzinga
Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate
February 14, 2025
From Benzinga
Robinhood's January Metrics Shine, But Crypto Notional Trading Volume Hits A Speed Bump Sequentially
February 14, 2025
From Benzinga
Pacific Gas & Electric Holds The Line On Q4 EPS Amid Grid Modernization Push: Details
February 14, 2025
From Benzinga
From Benzinga
Lottery.com Bets Big On International Growth With New Gaming Tech Acquisition; Stock Jumps
February 14, 2025
From Benzinga
Pfizer's Talzenna/Xtandi Combo Improves Survival Outcomes In Metastatic Castration-Resistant Prostate Cancer
February 14, 2025
From Benzinga
GoDaddy Falls On Q4 EPS Miss, But 2025 Outlook Promises AI-Powered Growth And Cash Flow Surge
February 14, 2025
From Benzinga
Albany International To Shift Operations In Italy: What's Next?
February 14, 2025
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.